tert‐Butanol
MAK-Begründung, Nachtrag
Andrea Hartwig1 (Vorsitz der Ständigen Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe, Deutsche Forschungsgemeinschaft)MAK Commission2
1 Institut für Angewandte Biowissenschaften, Abteilung Lebensmittelchemie und Toxikologie, Karlsruher Institut für Technologie (KIT), Adenauerring 20a, Geb. 50.41, 76131 Karlsruhe, Deutschland
2 Ständige Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe, Deutsche Forschungsgemeinschaft, Kennedyallee 40, 53175 Bonn, Deutschland
Abstract
The German Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area has re‐evaluated the Pregnancy Risk Group of
In rats, fetal weights were reduced at 2000 ml/m3, the LOAEC for developmental toxicity after inhalation. A 95 % lower confidence limit of the benchmark dose for developmental toxicity of 1600 ml/m3 was calculated. After now considering the increased respiratory volume at the workplace (see List of MAK and BAT values, chapters I b and I c) this concentration corresponds to 800 ml/m3 at the workplace. The difference to the MAK value of 20 ml/m3 is still sufficient so that damage to the embryo or foetus is unlikely when the MAK value is observed.
In a screening study based on OECD guideline 421 the NOAEL for fetotoxicity is 400 mg/kg body weight and day in rats. After toxicokinetic scaling this dose corresponds to a concentration of 233 ml/m3 at the workplace. The difference between the NOAEL for fetotoxicity for rats and the MAK value of 20 ml/m3 confirms the assignment to Pregnancy Risk Group C.
For mice, no NOAEL for developmental toxicity was obtained. At the LOAEL for developmental toxicity after gavage of 1600 mg/kg body weight and day, increased numbers of resorptions and reduced litter size, but no malformations occurred. After toxicokinetic scaling this dose corresponds to a concentration of 553 ml/m3 at the workplace. The difference between the LOAEL for developmental toxicity for mice and the MAK value does not contradict the retention of the assignment to Pregnancy Risk Group C, particularly as a bolus administration (gavage) is considered to be a worst case compared with a continuous exposure at the workplace.
